Role of adenosine in asthma

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 333-336

  Feoktistov, Igor ^a   Biaggioni, Italo ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Adenosine; Asthma; Enprofylline; Mast cells; Purinergic receptors

Indexed keywords

ADENOSINE; ENPROFYLLINE; HISTAMINE; PROSTAGLANDIN D2; PURINE RECEPTOR; RECEPTOR SUBTYPE; THEOPHYLLINE; TRYPTASE;

ASTHMA; BRONCHOSPASM; CELL ACTIVATION; CONFERENCE PAPER; HUMAN; IN VITRO STUDY; LUNG LAVAGE; MEDIATOR RELEASE; NONHUMAN; PERITONEUM MAST CELL;

EID: 0030428259     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<333::AID-DDR14>3.0.CO;2-2     Document Type: Conference Paper

References (28)

1. 3 adenosine receptors mediate degranulation of canine BR mastocytoma cells. Drug Dev Res 37:147.
2. Biaggioni I, Paul S, Puckett A, Arzubiaga C (1991): Caffeine and theophellyne as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 258:588-593.
3. Bjorck T, Gustafsson LE, Dahlen SE (1992): Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparantly acts inderectly by liberation of leukotriens and histamine. Am Rev Respir Dis 145:1087-1091.
4. Church MK, Hughes PJ, Vardey CJ (1986): Studies on the receptor mediating cyclic AMPindependent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol 87:233-242.
5. Cushley MJ, Tattersfield AE, Holgate ST (1984): Adenosine-induced bronchoconstriction in asthma. Am Rev Respir Dis 129:380-384.
6. Drake I, Routledge PA, Richards R (1994): Bronchospasm induced by intravenous adenosine. Hum Exp Toxicol 13:263-265.
7. Eagle KA, Boucher CA (1989): Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients (Editorial). Chest 95:258-289.
8. Feoktistov I, Biaggioni I (1993): Characterization of adenosine receptors in human erythroleukemia cells. Further evidence for heterogeneity of adeuosine A2 receptors. Mol Pharmacol 43:909-914.
9. Feoktistov I, Biaggioni I (1995): Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986.
10. Feoktistov I, Sheller JR, Biaggioni I. (1996): Adenosine A2b receptors in human lung cells as a targret for antiasthmatic methylxanthines. FASEB J 10):A1232.
11. Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fink JS, Reppert SM (1993): Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44:524-532.
12. Marquardt DL, Walker LL (1990): Modulation of mast cell responses to adenosine by agents that alter protein kinase C activity. Biochem Pharmacol 39:1929-1934.
13. Marquardt DL, Walker LL (1994): Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness. Agents Actions 43:7-12.
14. Marquardt DL, Parker CW, Sullivan TJ (1978): Potentiation of mast cell medator release by adenosine. J Immunol 120:871-878.
15. Marquardt DL, Walker LL, Heinemann S (1994): Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152:4508-4515.
16. Palmer TM, Stiles GL (1995): Neurotransmitter Receptors VII: Adenosine receptors. Neuropharmacology 34:683-694.
17. Pauwels RA, Germonpre PR, Kips JC, Joos GF (1995): Genetic control of inderect airway responsiveness in the rat. Clin Exp Allergy 25:55-60.
18. Peachell PT, Lichtenstein LM, Schleimer RP (1991): Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 256:717-726.
19. Persson CG, Andersson K, Kjellin G (1986): Effects of enprofylline and theophylline may show the role of adenosine. Life Sci 38:1057-1072.
20. Phillips GD, Scott VL, Richards R, Holgate ST (1989): Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 2:210-217.
21. Polosa R, Ng WH, Crimi N, Vanceri C, Holgate ST, Church MK, Mistretta A (1995): Release of mast cell-derived mediators after en-dobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 151:624-629.
22. Rafferty P, Beasley CR, Holgate ST (1987): The contribution of histainine to immediate bronchoconstriction provoked by inhaled allergen and adenosine-5′ monophosphate in atopic asthma. Am Rev Respir Dis 136:369-373.
23. Rail TW (1982): Evolution of the mechanisms of action of methylxanthines: from calcium mobilizers to antagonists of adenosine receptors. Pharmacologist 24:277-287.
24. Ramkumar, V., Stiles, G.L., Beaven, M.A., and Ali, H. (1993): The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268: 16887-16890.
25. Ramkumar V, Wilson M, Dhanraj DN, Gettys TW, Ali H (1995): Dexamethasone up-regulates A3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. J Immunol 154:5436-5443.
26. Salvatore CA, Jacobson MA, Taylor HE, Linden J, Johnson RG (1993): Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci 90:10365-10369.
27. Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK (1991): Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
28. Zhou Q, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O (1992): Molecular cloning and characterizaion of an adenosine receptor: The A3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.